An investigational blood test for type 1 diabetes can accurately detect the disorder's characteristic autoimmunity with only ...

Autoantibodies against GFAP may represent a new and early serum marker of high diabetes ... (1:150), 3.5, 5, 6, 8, 10 and 20 weeks old, respectively; lane 8, 1:1,000 IgG GFAP antibody. B-and T ...

For the first time, scientists in China reprogrammed a woman's fat cells ... for destruction by the immune system. For this treatment to be appropriate for more patients with type 1 diabetes ...

Genetics play a role in type 1 diabetes. You may be more likely to develop this autoimmune condition if you have a parent or immediate family member with a diagnosis. Type 1 diabetes is an ...

A panelist discusses how type 1 diabetes (T1D) is frequently misdiagnosed in adults due to its overlapping clinical features ...

Stem cell-derived pancreatic islets are being studied as a rich transplantable source for insulin production, a therapeutic ...

For example, agents used in NOD mice from birth (a time without β-cell destruction) may not be applicable to treatment of humans identified immediately before the onset of type 1 diabetes (when ...

In a major breakthrough for diabetes treatment, scientists have found a new way to regenerate insulin-producing cells. This ...

Type 1 diabetes is an immune-mediated ... that a few islet antigen–specific T cells in a sea of nonspecific bystanders can drive complete beta-cell destruction 15, the question of whether ...

Researchers at The University of Queensland have dosed 5 participants in the first clinical trial of a potentially ...

Type 1 diabetes is a chronic autoimmune condition where the body's immune system mistakenly attacks the insulin-producing cells in the pancreas. The destruction of the insulin-making cells prevents ...

Michael Dosch pSC autoimmunity in human T1D. a, Proliferative T-cell responses to GFAP (green) and S100ß (yellow) in peripheral blood mononuclear cells from newly diabetic children, ICA ...